Clinical Trial Update: Reformulated PG324 Ophthalmic Solution for Intraocular Pressure Reduction [Phase 3]

View source ↗

Summary

Phase 3 trial update reporting completion of evaluation for reformulated PG324 ophthalmic solution aimed at reducing intraocular pressure. The conditions studie…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• PG324 ophthalmic solution (PG324)

Snippet

Sponsor: Alcon Research | Conditions: Ocular Hypertension, Open Angle Glaucoma | Phase 3 | Status: COMPLETED